- Home
- BGNE vs GEN Comparison
BGNE vs GEN Comparison
Compare BGNE & GEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGNE
- GEN
- Stock Information
- Founded
- BGNE 2010
- GEN 1982
- Country
- BGNE Cayman Islands
- GEN United States
- Employees
- BGNE N/A
- GEN N/A
- Industry
- BGNE Biotechnology: Pharmaceutical Preparations
- GEN Computer Software: Prepackaged Software
- Sector
- BGNE Health Care
- GEN Technology
- Exchange
- BGNE Nasdaq
- GEN Nasdaq
- Market Cap
- BGNE 19.2B
- GEN 18.8B
- IPO Year
- BGNE 2016
- GEN N/A
- Fundamental
- Price
- BGNE $175.87
- GEN $27.73
- Analyst Decision
- BGNE Buy
- GEN Buy
- Analyst Count
- BGNE 8
- GEN 4
- Target Price
- BGNE $253.69
- GEN $28.75
- AVG Volume (30 Days)
- BGNE 476.1K
- GEN 3.4M
- Earning Date
- BGNE 11-12-2024
- GEN 01-30-2025
- Dividend Yield
- BGNE N/A
- GEN 1.80%
- EPS Growth
- BGNE N/A
- GEN N/A
- EPS
- BGNE N/A
- GEN 0.99
- Revenue
- BGNE $3,351,304,621.00
- GEN $3,863,000,000.00
- Revenue This Year
- BGNE $969.39
- GEN $3.91
- Revenue Next Year
- BGNE $24.79
- GEN $3.38
- P/E Ratio
- BGNE N/A
- GEN $28.06
- Revenue Growth
- BGNE 50.22
- GEN 2.44
- 52 Week Low
- BGNE $126.97
- GEN $19.08
- 52 Week High
- BGNE $248.16
- GEN $31.72
- Technical
- Relative Strength Index (RSI)
- BGNE 34.52
- GEN 30.31
- Support Level
- BGNE $174.50
- GEN $29.26
- Resistance Level
- BGNE $180.00
- GEN $30.21
- Average True Range (ATR)
- BGNE 6.73
- GEN 0.71
- MACD
- BGNE -2.17
- GEN -0.36
- Stochastic Oscillator
- BGNE 3.24
- GEN 0.50
About BGNE BeiGene Ltd.
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2023, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 50% of BeiGene's revenue.
About GEN Gen Digital Inc.
Gen is a cybersecurity pure-play that offers security, identity protection, and privacy solutions to individual consumers. The firm's cyber safety offerings, via brands such as Norton, Avast, and LifeLock, have long maintained their positions as some of the most recognizable consumer-focused security and identity-protection products.